Hollywood’s Brightest Stars Unite For Stand Up To Cancer’s Live Broadcast On September 9th
HOLLYWOOD’S BRIGHTEST STARS UNITE FOR STAND UP TO CANCER’S
LIVE BROADCAST ON SEPTEMBER 9th
Ben Affleck, Matthew McConaughey, Emma Stone, Anna Kendrick, Josh Gad,
Niecy Nash, Eric Stonestreet, Alison Sweeney, Ken Jeong, Marcia Cross,
Greg Grunberg, Danielle Campbell, Charlie Wilson, Brittany Daniel and SU2C
Co-Founder Katie Couric Among Those to Appear in Live One-Hour Event
Executive Produced by Bradley Cooper
Special Performances by Celine Dion and Keith Urban with Little Big Town
LOS ANGELES, CA — August 16, 2016 – Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation (EIF), is proud to announce the Hollywood community is once again joining forces to support the fifth biennial televised fundraising special on Friday, Sept. 9 (8:00 – 9:00 PM ET/PT / 7:00 PM CT). Ben Affleck, Matthew McConaughey, Emma Stone, Anna Kendrick, Josh Gad, Niecy Nash, Eric Stonestreet, Alison Sweeney, Ken Jeong, Marcia Cross, Greg Grunberg, Danielle Campbell, Charlie Wilson, Brittany Daniel and SU2C Co-Founder Katie Couric will all appear in the inspiring broadcast. In addition, celebrated recording artists, Celine Dion and Keith Urban with Little Big Town will perform moving tributes in honor of all those standing up to cancer. Additional stars and performers will be announced in the coming weeks.
Academy Award®-nominated actor and founder of the Bradley Charles Cooper Foundation, Bradley Cooper, will executive produce the broadcast event and appear in it. Cooper will work alongside award-winning production team Done + Dusted, in collaboration with the Stand Up To Cancer production team.
The telecast will run on the major U.S. broadcast networks and a host of cable channels; it will be streamed worldwide via major online services; a Spanish-language version will run on major Spanish channels; and a Canadian-inclusive version will be shown by the principal English-language broadcasters and services in Canada.
Leading up to the live show, SU2C is rallying the nation in a powerful social media campaign, #Reasons2StandUp, inviting supporters to share, through photos and video posts, how cancer has impacted their lives. Whether standing up for a friend, family member, or a personal experience with the disease, #Reasons2StandUp reminds the world that we are all in this fight together. Select user-generated content will then be featured on the September 9th telecast.
“We all have a reason to stand up,” said Bradley Cooper, executive producer of the SU2C telecast. “Stand Up To Cancer is a sustained movement that impacts millions of lives. We honor the personal stories that motivate individuals to fight, and that highlight the urgent need to get new methods of treatment to the patients who so desperately need them.”
The telecast will broadcast live from The Music Center’s Walt Disney Concert Hall in downtown Los Angeles. ABC, CBS, FOX, and NBC, along with American Forces Network, ASPiRE, AUDIENCE Network, Bloomberg TV, Bravo, Comedy Central, Discovery Life, E! Entertainment, EPIX, ESPNEWS, FM, FS2, Fusion, FXM, Great American Country, HBO, HLN, ION Television, LMN, Logo, MLB Network, National Geographic, Pivot, RLTV, SHOWTIME, Smithsonian Channel, STARZ, STARZ ENCORE, TBS, Tr3s, VH1, and WGN America are donating one hour of simultaneous commercial-free primetime for the telecast. For the first time, there will be a Spanish version of the Stand Up To Cancer telecast airing nationally on Galavision, HBO Latino, STARZ ENCORE ESPAÑOL and Univision Deportes, and locally on Univision Puerto Rico. In addition, the show will stream live on SU2C’s Facebook page, Yahoo, SU2C’s YouTube page, MLB.com and in Spanish on Univision.com. USA Network will air the Stand Up To Cancer telecast on Friday, Sept. 9 at 11:00 PM – 12:00 AM ET/PT / 10:00 PM CT. It will also be available on Hulu on Saturday, Sept. 10.
This star-studded appeal continues to build public support for groundbreaking translational research, supported through SU2C programs, that can provide patients with new therapies to save lives now. SU2C brings together scientists from different disciplines across institutions and international boundaries to collaborate on finding new treatments that can account for more than 80 percent of all cancer diagnoses in the US and Canada.
The first four SU2C telecasts took place on September 5, 2008, September 10, 2010, September 7, 2012, and September 5, 2014, and were made available to more than 190 countries. The first Canadian-inclusive SU2C telecast aired in 2014, and this year’s show will again air across all four major English-language Canadian broadcasters: CBC, City, CTV, and Global. Additionally, Canadian services AMI, Bloomberg TV Canada, CHCH, CHEK, Fight Network, Hollywood Suite, Joytv, NTV and TLN will also air the telecast, and it will be available on-demand on shomi and TELUS Optik TV in Canada.
SU2C is a major force in the development of innovative and more effective cancer treatments such as immunotherapy, which empowers the body’s own immune system to fight cancer cells. SU2C is supporting advancements in immunotherapy treatments for leukemia, melanoma, and cancers of the pancreas, head and neck, lung, and ovary. SU2C also supports development of precision therapies tailored to the patient’s specific genetic and molecular makeup in prostate and colorectal cancers and melanoma, among others; new technology to accelerate research; early detection of colorectal cancer; prevention of ovarian cancer; and groundbreaking work on cancer stem cells and the epigenetics (processes that control so-called “packaging” of DNA) of cancer, among other new fields.
To date, more than $370 million has been pledged to support SU2C’s innovative model of collaborative cancer research. Since launching in 2008, Stand Up To Cancer has brought together more than 1,200 of the best and the brightest research scientists from more than 140 leading institutions in seven countries to fund 19 “Dream Teams,” and six translational research teams; as well as 36 early-career, innovative scientists carrying out high-risk, potentially high-reward projects. The research is aimed at ending cancer’s reign as a leading cause of death worldwide. SU2C-funded researchers have planned, launched or completed more than 160 clinical trials involving over 9,000 patients. Work by SU2C-supported researchers has led to FDA approval of two new treatments.
The American Association for Cancer Research (AACR), the world’s first and largest professional organization dedicated to advancing cancer research, is the official Scientific Partner of Stand Up To Cancer. AACR is responsible for administering the grants and providing scientific oversight in conjunction with the SU2C Scientific Advisory Committee (SAC).
As SU2C’s founding donor, Major League Baseball has provided both financial support and countless opportunities to build the Stand Up To Cancer grassroots movement by encouraging fans worldwide to get involved. In addition to MLB, SU2C’s “Visionary” donors include Bristol-Myers Squibb; Cancer Treatment Centers of America®; Genentech, a member of the Roche Group; Mastercard; and The Sidney Kimmel Foundation. Major donors and collaborators include American Airlines, American Cancer Society, CVS Health, Fifth Third Bank, The Lustgarten Foundation for Pancreatic Cancer Research, Merck, and Rally Health. Other key supporters and collaborators include Cancer Research Institute, Cancer Research UK, Dutch Cancer Society, Farrah Fawcett Foundation, Lilly Oncology, The Laura Ziskin Family Trust, Melanoma Research Alliance, National Ovarian Cancer Coalition, Ovarian Cancer Research Fund Alliance, The Parker Foundation, Prostate Cancer Foundation, St. Baldrick’s Foundation and Van Andel Research Institute.
Stand Up To Cancer Canada has launched two inaugural Dream Teams: SU2C Canada-CBCFBreast Cancer Dream Team and SU2C Canada Cancer Stem Cell Dream Team. Collaborators include Canadian Breast Cancer Foundation (CBCF), with support from CIBC; Canadian Institutes of Health Research; Cancer Stem Cell Consortium; Genome Canada; and the Ontario Institute for Cancer Research. AstraZeneca Canada and MasterCard are the first corporate supporters of SU2C Canada.
About Stand Up To Cancer
Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, was established in 2008 by film and media leaders who utilize the industry’s resources to engage the public in supporting a new, collaborative model of cancer research, and to increase awareness about cancer prevention as well as progress being made in the fight against the disease. As SU2C’s scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Phillip A. Sharp, PhD, conduct rigorous, competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.
Current members of the SU2C Council of Founders and Advisors (CFA) include Katie Couric, Sherry Lansing, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, Ellen Ziffren, and Kathleen Lobb. The late Laura Ziskin was also a co-founder. SU2C was formally launched on May 27, 2008. Sung Poblete, Ph.D., R.N., has served as SU2C’s president since 2011.
For more information on Stand Up To Cancer, visit www.standup2cancer.org.
About the Entertainment Industry Foundation
Founded in 1942, the Entertainment Industry Foundation (EIF) is a multifaceted organization that occupies a unique place in the world of philanthropy. By mobilizing and leveraging the powerful voice and creative talents of the entertainment industry, as well as cultivating the support of organizations (public and private) and philanthropists committed to social responsibility, EIF builds awareness and raises funds, developing and enhancing programs on the local, national and global level that facilitate positive social change. For more information, visit www.eifoundation.org.
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 36,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates in more than 107 countries and territories around the world; over 30 percent of members live outside the United States and Canada. The AACR convenes more than 20 conferences and educational workshops every year, the largest of which is the AACR Annual Meeting with nearly 19,500 attendees in 2016. The AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers and funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of SU2C, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual grants. For more information about the AACR, visit www.AACR.org.
Media Contacts (US):
For questions regarding red carpet or day of event coverage, please contact SLATE PR:
Andy Gelb/Elyse Weissman
To apply for red carpet press credentials for this event, you must fill out the online application by Friday, August 26: https://slatepr.wufoo.com/forms/stand-up-to-cancer-2016/